Frontlight ResearchEarly access
TerminatedNo phase
Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME)
Key facts
- Who runs it
- Suzhou Zenith Vascular SciTech Limited
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 1 person enrolled
- Started
- 3 Jan 2024
- Ended
- 17 Dec 2024
- Type of study
- Interventional
- Treatments tested
- Stent-Retriever
- Record updated
- 18 September 2025
- Why it stopped
- The clinical trial was terminated ahead of schedule due to strategic changes within the company.
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- 1.18≤ age ≤75, no gender limitation; 2.patients clinically diagnosed as acute pulmonary embolism requiring pulmonary artery thrombosis clearance; 3.RV/LV ratio ≥0.9; 4.Patients who agreed to participate in the study and voluntarily signed the informed consent
Who cannot take part
- Patients who cannot receive antiplatelet or anticoagulant therapy
- Patients who underwent cardiovascular or pulmonary open surgery within 7 days before peocedure
- Patients treated with extracorporeal membrane oxygenation
- Patients with known severe pulmonary hypertension
- Patients with known structural heart disease
- Patients with intracardiac thrombosis
- Patients known to be allergic to contrast agents
- Patients with diseases that may cause difficulty in treatment or evaluation (such as malignant tumor, acute infectious disease, sepsis, general condition that cannot tolerate procedure, life expectancy less than one year, etc.)
- Other conditions not suitable for inclusion judged by the researcher
- Patients with history of chronic left heart failure and left ventricular ejection fraction ≤30%
- Patients with abnormal renal function (serum creatinine > 1.8 mg/dL or >159 umol/L)
- Patients with known coagulopathy or bleeding tendency (platelet <100×109/L, or INR> 3)
- Patients with systolic blood pressure<90 mmHg and lasting for 15 minutes or requiring maintenance of systolic blood pressure ≥ 90 mmHg
- Patients with Hematocrit <28%
- Patients with left bundle branch block
- Females who are pregnant or in lactation
- Patient is currently enrolled in another investigational study protocol
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To evaluate treatment outcomes of patients diagnosed with pulmonary embolism.
The group in the trial
- Stent-Retriever armTreatment being tested
Device: Stent-Retriever
Treatment: Stent-Retriever
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective, Multicenter, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Thrombectomy Devices for the Treatment of Acute Pulmonary Embolism
- Record updated
- 18 September 2025